*Indicates a required field.
Treatment status (optional):
By completing the required fields and clicking "Submit," I confirm that I am a US resident 18 years of age or older and agree to receive information about JIDEYTRO for ROS1+ NSCLC, and other related resources from Nuvalent.
I also agree to receive disease-state information from Nuvalent and its partners and affiliates. Nuvalent may use this information to provide me with information, resources, and communications.
I understand that I may unsubscribe from these emails at any time by clicking “Unsubscribe.” Instructions for which will be included in each email I receive. I further understand that Nuvalent will not sell my personal information and will use my personal information as described in the Privacy Policy. By clicking “Submit,” I agree to Nuvalent’s Terms of Use and Privacy Policy.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.